Cars-Jan is a Partner / civil-law notary (notaris) in the corporate M&A department of Osborne Clarke in Amsterdam and specialises in the various aspects of (notarial) corporate law, particularly in relation to (re)structuring, mergers and acquisitions, investment funds and private equity and other matters of company and corporate law for national and international clients.
Cars-Jan joined Osborne Clarke as per the 1st of July 2015. He became a Partner and civil-law notary in 2007.
His work includes among other things providing advices on (re)structuring, setting up legal entities as well as partnerships and the matters he deals with include corporate acquisitions and disposals, mergers and split-offs, security rights (pledge and mortgage), share issues and transfers, partnerships and establishing (employee) participation plans.
For various corporate clients, Cars-Jan also advises on transactions related to (commercial) real estate. He provides notarial services regarding the acquisition, transfer and finance of real estate portfolios and (commercial) properties.
Cars-Jan is a member of the Royal Notarial Regulatory Body (Koninklijke Notariële Beroepsorganisatie or KNB), of the Association of Notarial Corporate Specialists (Vereniging van Notarieel Ondernemingsrecht Specialisten) and he is a participant in the KNB Blockchain Innovatielab.
Wireless Logic Holding
Advised Wireless Logic Group, Europe’s leading Internet of Things (IoT) connectivity platform provider on the acquisition of New Line Mobile, read more.
ASN Beleggingsinstellingen Beheer B.V.
Advised ASN Beleggingsinstellingen Beheer B.V. on the split-up of a listed umbrella fund into listed UCITS and AIF umbrella funds, read more .
DDL Diagnostic Laboratory
Advised ViroClinics and Summit Partners on the acquisition of DDL Diagnostic Laboratory.
Advised Oaky on $9.5M Series A financing by PeakSpan Capital, read more.
Advised Ancala Partners on its majority acquisition of FORE Freedom and Glasvezel Groep Nederland, read more.
Advised the owners of MediaMonks on its sale to S4 Capital, read more.
Advised on the sale of Isobionics to BASF, read more.
Advised on the sale of Breath Therapeutics to Zambon.